Skip to content

By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.

Peter Attia MDPeter Attia MD

181 - Viewing cancer through an evolutionary lens: a radically different approach to treatment

Robert (Bob) Gatenby is a radiologist who specializes in exploring theoretical and experimental models of evolutionary dynamics in cancer and cancer drug resistance. He has developed an adaptive therapy approach for treating cancer which has shown promise in improving survival times with less cumulative drug use. In this episode, Bob explains what brought him into medicine, his search for organizing principles from which to understand cancer, and the mathematical modeling of other complex systems that led him to model the dynamics of tumor cell changes in cancer. He discusses his pilot clinical trial treating metastatic prostate cancer, in which he used an evolutionary game theory model to analyze patient-specific tumor dynamics and determine the on/off cycling of treatment. He describes how altering chemotherapy to maximize the fitness ratio between drug-sensitive and drug-resistant cancer cells can increase patient survival and explains how treatment of metastatic cancer may be improved using adaptive therapy and strategic sequencing of different chemotherapy drugs. We discuss: 00:00:00 - intro 00:00:10 - Bob’s unlikely path to medicine and his disappointment with his medical school experience 00:12:30 - Rethinking the approach to cancer: using first principles and applying mathematical models 00:29:27 - Relating predator prey-models to cancer 00:37:50 - Insights into cancer gathered from ecological models of pests and pesticides 00:47:27 - Bob’s pilot clinical trial: the advantages of adaptive therapy compared to standard prostate cancer treatment 00:55:25 - New avenues of cancer therapy: utilizing drug-sensitive cancer cells to control drug-resistant cancer cells 01:03:29 - The vulnerability of small populations of cancer cells and the problem with a “single strike” treatment approach 01:14:30 - Using a sequence of therapies to make cancer cells more susceptible to targeted treatment 01:25:56 - How immunotherapy fits into the cancer treatment toolkit 01:31:25 - Insights into why cancer spreads, where it metastasizes, and the source-sync trade off of cancer 01:42:45 - Defining Eco- and Evo-indices and how they can be used to make better clinical decisions 01:55:24 - Advantages of early screening for cancer 01:58:36 - Bob’s goals for follow-ups after the success of his prostate cancer trial 02:09:22 - Treatment options for cancer patients who have been told they have “failed therapy” Show notes page: https://peterattiamd.com/robertgatenby/ -------- About: The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 30 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more. Peter is a physician focusing on the applied science of longevity. His practice deals extensively with nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology to increase lifespan (delay the onset of chronic disease), while simultaneously improving healthspan (quality of life). Learn more: https://peterattiamd.com Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter Connect with Peter on: Facebook: http://bit.ly/PeterAttiaMDFB Twitter: http://bit.ly/PeterAttiaMDTW Instagram: http://bit.ly/PeterAttiaMDIG Subscribe to The Drive: Apple Podcast: http://bit.ly/TheDriveApplePodcasts Overcast: http://bit.ly/TheDriveOvercast Spotify: http://bit.ly/TheDriveSpotify Google Podcasts: http://bit.ly/TheDriveGoogle

Peter AttiahostRobert Gatenbyguest
Oct 25, 20212h 18mWatch on YouTube ↗

Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.

Episode Details

EPISODE INFO

Released
October 25, 2021
Duration
2h 18m
Channel
Peter Attia MD
Watch on YouTube
▶ Open ↗

EPISODE DESCRIPTION

Robert (Bob) Gatenby is a radiologist who specializes in exploring theoretical and experimental models of evolutionary dynamics in cancer and cancer drug resistance. He has developed an adaptive therapy approach for treating cancer which has shown promise in improving survival times with less cumulative drug use. In this episode, Bob explains what brought him into medicine, his search for organizing principles from which to understand cancer, and the mathematical modeling of other complex systems that led him to model the dynamics of tumor cell changes in cancer. He discusses his pilot clinical trial treating metastatic prostate cancer, in which he used an evolutionary game theory model to analyze patient-specific tumor dynamics and determine the on/off cycling of treatment. He describes how altering chemotherapy to maximize the fitness ratio between drug-sensitive and drug-resistant cancer cells can increase patient survival and explains how treatment of metastatic cancer may be improved using adaptive therapy and strategic sequencing of different chemotherapy drugs. We discuss: 00:00:00 - intro 00:00:10 - Bob’s unlikely path to medicine and his disappointment with his medical school experience 00:12:30 - Rethinking the approach to cancer: using first principles and applying mathematical models 00:29:27 - Relating predator prey-models to cancer 00:37:50 - Insights into cancer gathered from ecological models of pests and pesticides 00:47:27 - Bob’s pilot clinical trial: the advantages of adaptive therapy compared to standard prostate cancer treatment 00:55:25 - New avenues of cancer therapy: utilizing drug-sensitive cancer cells to control drug-resistant cancer cells 01:03:29 - The vulnerability of small populations of cancer cells and the problem with a “single strike” treatment approach 01:14:30 - Using a sequence of therapies to make cancer cells more susceptible to targeted treatment 01:25:56 - How immunotherapy fits into the cancer treatment toolkit 01:31:25 - Insights into why cancer spreads, where it metastasizes, and the source-sync trade off of cancer 01:42:45 - Defining Eco- and Evo-indices and how they can be used to make better clinical decisions 01:55:24 - Advantages of early screening for cancer 01:58:36 - Bob’s goals for follow-ups after the success of his prostate cancer trial 02:09:22 - Treatment options for cancer patients who have been told they have “failed therapy” Show notes page: https://peterattiamd.com/robertgatenby/ -------- About: The Peter Attia Drive is a weekly, ultra-deep-dive podcast focusing on maximizing health, longevity, critical thinking…and a few other things. With over 30 million episodes downloaded, it features topics including fasting, ketosis, Alzheimer’s disease, cancer, mental health, and much more. Peter is a physician focusing on the applied science of longevity. His practice deals extensively with nutritional interventions, exercise physiology, sleep physiology, emotional and mental health, and pharmacology to increase lifespan (delay the onset of chronic disease), while simultaneously improving healthspan (quality of life). Learn more: https://peterattiamd.com Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter Connect with Peter on: Facebook: http://bit.ly/PeterAttiaMDFB Twitter: http://bit.ly/PeterAttiaMDTW Instagram: http://bit.ly/PeterAttiaMDIG Subscribe to The Drive: Apple Podcast: http://bit.ly/TheDriveApplePodcasts Overcast: http://bit.ly/TheDriveOvercast Spotify: http://bit.ly/TheDriveSpotify Google Podcasts: http://bit.ly/TheDriveGoogle

SPEAKERS

  • Peter Attia

    host

    Physician and host of The Drive podcast focused on medicine, longevity, and health science.

  • Robert Gatenby

    guest

    Physician-scientist and cancer researcher known for evolutionary/ecological and mathematical modeling approaches to cancer and adaptive therapy.

EPISODE SUMMARY

In this episode of Peter Attia MD, featuring Peter Attia and Robert Gatenby, 181 - Viewing cancer through an evolutionary lens: a radically different approach to treatment explores evolutionary Ecology Reframes Cancer Treatment: Adaptive Therapy and Extinction Strategies Gatenby describes moving from physics to medicine and radiology, then building mathematical population models of cancer after finding oncology research lacked organizing first principles.

RELATED EPISODES

409 ‒ Inside modern drug development: the science, economics, and regulatory hurdles

409 ‒ Inside modern drug development: the science, economics, and regulatory hurdles

#117 – Stanley Perlman, M.D., Ph.D.: Insights from a coronavirus expert on COVID-19

#117 – Stanley Perlman, M.D., Ph.D.: Insights from a coronavirus expert on COVID-19

#150-Senator Bill Frist, MD: A modern Renaissance man's journey through science, politics & business

#150-Senator Bill Frist, MD: A modern Renaissance man's journey through science, politics & business

#130 - Carol Tavris, Ph.D. & Elliot Aronson, Ph.D.: Recognizing and overcoming cognitive dissonance

#130 - Carol Tavris, Ph.D. & Elliot Aronson, Ph.D.: Recognizing and overcoming cognitive dissonance

#96–David Epstein: How range of experience leads to better performance in a highly specialized world

#96–David Epstein: How range of experience leads to better performance in a highly specialized world

#125 - John Arnold: The most prolific philanthropist you may not have heard of

#125 - John Arnold: The most prolific philanthropist you may not have heard of

Get more out of YouTube videos.

Read along on your phone, search it beside the video, or ask your favorite AI app what was said.